Nothing Special   »   [go: up one dir, main page]

BR112013004436A2 - composições e usos de materiais com atividade microbicida alta e toxicidade baixa - Google Patents

composições e usos de materiais com atividade microbicida alta e toxicidade baixa

Info

Publication number
BR112013004436A2
BR112013004436A2 BR112013004436A BR112013004436A BR112013004436A2 BR 112013004436 A2 BR112013004436 A2 BR 112013004436A2 BR 112013004436 A BR112013004436 A BR 112013004436A BR 112013004436 A BR112013004436 A BR 112013004436A BR 112013004436 A2 BR112013004436 A2 BR 112013004436A2
Authority
BR
Brazil
Prior art keywords
compositions
materials
low toxicity
microbicidal activity
high microbicidal
Prior art date
Application number
BR112013004436A
Other languages
English (en)
Inventor
Diego Bentitez
Jarrod A Hanson
Lucas Koziol
Michael P Bevilacqua
Timothy J Deming
Original Assignee
Amicrobe Inc
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amicrobe Inc, Univ California filed Critical Amicrobe Inc
Publication of BR112013004436A2 publication Critical patent/BR112013004436A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/18Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463Organic compounds; Microorganisms; Enzymes
    • A23L3/3526Organic compounds containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Microbiology (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)

Abstract

composições e usos de materiais com atividade microbicida alta e toxicidade baixa. trata-se de copolipeptídeos sintéticos microbicidas aprimorados que contém resíduos de aminoácidos catiônico e podem ser baseados em uma sequência de bloco. esses microbicidas mostram toxicidade de mamífero baixa e podem sofrer automontagem direcionada. os copolipeptídeos sintéticos da invenção são utéis no tratamento de ferimentos e outras infecções.
BR112013004436A 2010-08-23 2011-08-23 composições e usos de materiais com atividade microbicida alta e toxicidade baixa BR112013004436A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37619510P 2010-08-23 2010-08-23
PCT/US2011/048869 WO2012027411A2 (en) 2010-08-23 2011-08-23 Compositions and uses of materials with high antimicrobial activity and low toxicity

Publications (1)

Publication Number Publication Date
BR112013004436A2 true BR112013004436A2 (pt) 2016-06-21

Family

ID=45724032

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013004436A BR112013004436A2 (pt) 2010-08-23 2011-08-23 composições e usos de materiais com atividade microbicida alta e toxicidade baixa

Country Status (16)

Country Link
US (3) US9017730B2 (pt)
EP (1) EP2608800B1 (pt)
JP (1) JP5902171B2 (pt)
CN (1) CN103260635A (pt)
AU (3) AU2011293468B2 (pt)
BR (1) BR112013004436A2 (pt)
CA (2) CA2809093C (pt)
DK (1) DK2608800T3 (pt)
ES (1) ES2622498T3 (pt)
HU (1) HUE032899T2 (pt)
LT (1) LT2608800T (pt)
MX (1) MX342039B (pt)
PL (1) PL2608800T3 (pt)
PT (1) PT2608800T (pt)
SG (1) SG188281A1 (pt)
WO (1) WO2012027411A2 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE032899T2 (hu) 2010-08-23 2017-11-28 Univ California Nagy mikrobaellenes aktivitással és kis toxicitással rendelkezõ anyagok kompozíciói és alkalmazásai
CA2867903C (en) * 2012-03-23 2023-02-14 Amicrobe, Inc. Compositions and uses of antimicrobial materials with tissue-compatible properties
DK3185882T3 (da) * 2014-08-29 2020-01-27 Region Midtjylland Positivt ladede copolymerer til anvendelse som antimikrobielle midler
WO2016054432A1 (en) 2014-10-01 2016-04-07 The Regents Of The University Of California Non-ionic and thermoresponsive diblock copolypeptide hydrogels for delivery of molecules and cells
CN106674329B (zh) * 2015-11-05 2021-07-23 程家维 具备抗微生物、抗癌/促进伤口愈合活性的肽及其用途
CN105708592B (zh) * 2016-04-17 2018-04-24 河南科技大学第一附属医院 一种手外科术后的手臂支架
AU2018249552A1 (en) 2017-04-06 2019-10-31 Amicrobe, Inc. Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety
CN111234034B (zh) * 2020-01-22 2021-10-08 国家纳米科学中心 一种调控细胞膜受体的多肽组合物及其制备方法和应用
AU2021252544A1 (en) * 2020-04-08 2022-11-03 Amicrobe, Inc. Compositions and uses of locally applied synthetic amino acid polymers for prevention and treatment of viral infections
US12090206B2 (en) 2020-04-23 2024-09-17 The Regents Of The University Of California Compositions comprising tri- and penta-block synthetic copolypeptide hydrogels
US20240350579A1 (en) * 2020-08-10 2024-10-24 Gel4Med, Inc. Antifungal matrix formed from peptide hydrogels
CN112933108B (zh) * 2021-02-05 2024-07-23 华东理工大学 掺杂多肽聚合物的骨髓腔填充物及在骨髓炎治疗中的用途
CN114748681B (zh) * 2022-04-13 2023-03-10 四川大学 一种可注射自愈合水凝胶敷料及其制备方法、用途

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856308A (en) * 1996-09-27 1999-01-05 Haemacure Corporation Artificial collagen
US6686446B2 (en) 1998-03-19 2004-02-03 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
AU2001275409A1 (en) 2000-06-08 2001-12-17 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
US20050079159A1 (en) 2001-06-13 2005-04-14 Massachusetts Instiute Of Technology In vivo bioreactors
AU2002365135A1 (en) 2001-10-23 2003-07-09 Anteon Corporation Integrated oxygen generation and carbon dioxide absorption method, apparatus and systems
US20030147958A1 (en) * 2002-01-29 2003-08-07 Cheol-Hee Ahn Biodegradable multi-block copolymers of poly(amino acid)s and poly(ethylene glycol) for the delivery of bioactive agents
US7204997B2 (en) 2002-01-29 2007-04-17 Supratek Pharma Inc. Responsive microgel and methods related thereto
CA2519023C (en) * 2003-03-17 2014-05-20 The Trustees Of The University Of Pennsylvania Facially amphiphilic polymers and oligomers and uses thereof
US7329638B2 (en) 2003-04-30 2008-02-12 The Regents Of The University Of Michigan Drug delivery compositions
EP1644382B1 (en) * 2003-07-11 2008-03-05 Theravance, Inc. Cross-linked glycopeptide-cephalosporin antibiotics
EP1907444B1 (en) 2005-04-01 2009-08-19 Intezyne Technologies Incorporated Polymeric micelles for drug delivery
EP1868629B1 (en) 2005-04-15 2014-10-22 Arizona Biomedical Research Commission Therapeutic fusion peptides for the treatment of metastatic cancer
US9505867B2 (en) 2005-05-31 2016-11-29 Ecole Polytechmique Fédérale De Lausanne Triblock copolymers for cytoplasmic delivery of gene-based drugs
WO2007095005A1 (en) * 2006-02-10 2007-08-23 Z-Medica Corporation Agents and devices for providing blood clotting functions to wounds
US9168329B2 (en) * 2006-09-01 2015-10-27 Wisconsin Alumni Research Foundation Beta-peptides with antifungal activity
JP2010511630A (ja) * 2006-12-01 2010-04-15 ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア 自己組織化ブロックコポリマーのベシクル、ならびにその生成および使用法
US20080311045A1 (en) 2007-06-06 2008-12-18 Biovaluation & Analysis, Inc. Polymersomes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo
JP5143231B2 (ja) * 2007-08-21 2013-02-13 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 共重合体安定化エマルション
EP2400974B1 (en) 2009-02-18 2017-09-06 The Regents of the University of California Synthetic diblock copolypeptide hydrogels for use in the central nervous system
HUE032899T2 (hu) 2010-08-23 2017-11-28 Univ California Nagy mikrobaellenes aktivitással és kis toxicitással rendelkezõ anyagok kompozíciói és alkalmazásai
EP2961758A4 (en) 2013-02-26 2016-10-19 Univ California AMPHIPHIL DERIVATIVES OF BLOCK COPOLYPEPTIDES WITH THIOETHERS

Also Published As

Publication number Publication date
MX342039B (es) 2016-09-09
AU2016203767B2 (en) 2018-04-26
CA2912577C (en) 2019-02-19
AU2011293468A1 (en) 2013-03-14
US9017730B2 (en) 2015-04-28
CA2809093C (en) 2015-11-24
EP2608800A2 (en) 2013-07-03
WO2012027411A2 (en) 2012-03-01
PL2608800T3 (pl) 2017-08-31
DK2608800T3 (da) 2017-05-01
ES2622498T3 (es) 2017-07-06
CA2912577A1 (en) 2012-03-01
US10448634B2 (en) 2019-10-22
US20200288709A1 (en) 2020-09-17
CN103260635A (zh) 2013-08-21
LT2608800T (lt) 2017-05-10
WO2012027411A9 (en) 2012-05-31
WO2012027411A3 (en) 2012-07-19
US20130267458A1 (en) 2013-10-10
AU2011293468B2 (en) 2014-05-15
EP2608800B1 (en) 2017-01-18
MX2013002122A (es) 2013-06-05
PT2608800T (pt) 2017-05-03
US20150366193A1 (en) 2015-12-24
AU2016203767A1 (en) 2016-06-23
SG188281A1 (en) 2013-04-30
JP5902171B2 (ja) 2016-04-13
CA2809093A1 (en) 2012-03-01
HUE032899T2 (hu) 2017-11-28
JP2013536242A (ja) 2013-09-19
AU2014213503B2 (en) 2016-03-10
AU2014213503A1 (en) 2014-09-04
EP2608800A4 (en) 2014-01-22

Similar Documents

Publication Publication Date Title
BR112013004436A2 (pt) composições e usos de materiais com atividade microbicida alta e toxicidade baixa
CY1119660T1 (el) Antibakthpiakh απο toy στοματος συνθεση
BR112015004600A2 (pt) composições de gluconato de clorexidina, sistemas e artigos de resina
UY31673A1 (es) &#34;derivados heterocíclicos de urea y métodos de uso de los mismos-211&#34;
BR112013026032A2 (pt) composições nutricionais incluindo ácidos graxos de cadeia ramificada para cicatrização de ferida
BR112018004536A2 (pt) peptídeos de endereçamento à cartilagem
BR112013010976A2 (pt) &#34;artigos que incorporam polímero absorvente e composto ceragenin.&#34;
BR112012024806A2 (pt) membro de fixação arcado e implante intervertebral
BR112012017269A2 (pt) compostos heterocíclicos tricíclicos, composições e métodos de uso dos mesmos
BRPI0516857A (pt) dispositivos biomédicos que contêm copolìmeros de bloco anfifìlico
BR112015013123A2 (pt) inibidores de beta-lactamase
BR112015011933A2 (pt) composições bacterianas sinérgicas e métodos de produção e uso das mesmas
BR112015019044A2 (pt) adesivos antimicrobianos tendo proprieda-des aperfeiçoadas
BR112018015273A2 (pt) derivados de benzimidazol como moduladores de ror-gama
CY1114960T1 (el) Συνθεσεις που περιλαμβανουν τραμαδολη και σελεκοξιμπη στην θεραπεια πονου
BR112015007878A2 (pt) composto compreendendo oligonucleotídeo modificado, composição, combinação e uso dos mesmos
EA200802184A1 (ru) Фармацевтические композиции с ингибиторами dpp iv
CL2013003472A1 (es) Compuestos derivados de halogenoalquil-1,3-oxazinas sustituidas, inhibidores de la bace1 y/o bace2; procedimiento de obtencion; composicion farmaceutica que los comprende; su uso en el tratamiento y/o profilaxis de enfermedades tales como diabetes, alzheimer, als, enfermedades autoinmunes inflamatorias, cancer, entre otras.
BRPI0810064B8 (pt) compostos contendo nitrogênio tricíclico como agentes antibacterianos, composições farmacêuticas que compreendem os ditos compostos e uso dos mesmos para o tratamento de infecções bacterianas em mamíferos
BR112015032341A2 (pt) conservação de composições para cuidados pessoais
CO6331421A2 (es) Gel de quitosano para aplicaciones dermatologicas proceso de obtencion y uso del mismo
CL2008001123A1 (es) Compuestos derivados de acido lipoico; formulacion farmaceutica que lo comprende; y uso en el tratamiento del cancer.
BRPI0709581A8 (pt) compostos de bicicloeteroarila como moduladores de px27 e seu uso
BR112016027871A2 (pt) composição para melhorar a memória, a função de aprendizado e/ou função cognitiva
CL2009000119A1 (es) Compuestos derivados de amino-bencimidazoles sustituidos; composicion farmaceutica; y su uso en el tratamiento del alzheimer.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]